A 75-million-year-old fossil from a bird about the size of a turkey vulture, discovered in Utah in 1992 by University of California, Berkeley, paleontologist Howard Hutchison, lay relatively untouched in the University of California Museum of Paleontology at Berkeley until doctoral student Jessie Atterholt learned about it in 2009 and asked to study it. Atterholt and Hutchison collaborated with Jingmai O’Conner, the leading expert on enantiornithines, to perform a detailed analysis of the fossil, which is deepening a mystery as to why only one family of birds survived the extinction o
UC San Francisco doctors working closely with UC Berkeley scientists plan to edit their genomes to correct rare genetic mutations and slow or halt progression of their diseases. If successful, the trials will inaugurate a new era of “genome surgery” — the precision targeting of genetic defects in the genome, using CRISPR-Cas9 customized to individual patients. Such “bespoke” therapies can benefit small groups of individuals or families with particular genetic defects that would never be addressed by large pharmaceutical companies.
An ancient group of microbes that contains some of the smallest life forms on Earth also has the smallest CRISPR gene-editing machinery discovered to date. The made by a group including Berkeley graduate student Lucas Harrington and Professor Jennifer Doudna of the Department of Molecular & Cell Biology.
The American Cancer Society will bestow its highest honor, the Medal of Honor, on Jennifer Doudna and four others — including former Vice President Joseph Biden Jr. The medal is awarded to distinguished individuals who have made valuable contributions in the fight against cancer through basic research, clinical research and cancer control.
Three UC Berkeley faculty members were elected this week to the National Academy of Medicine, considered one of the highest honors in health and medicine. Among them are John Kuriyan, a professor of molecular and cell biology and of chemistry; and Barbara Meyer, a professor of molecular and cell biology and a Howard Hughes Medical Institute investigator;
Assistant professor Ke Xu of chemistry and Denis Titov of molecular and cell biology — were among 89 recipients of “high-risk, high-reward” grants announced last week by the National Institutes of Health. The awards, which support “unusually innovative research from early career investigators” who have never received an NIH grant before, come with $1.5 million in direct funds for five years.
Immunologist James P. Allison today shared the 2018 Nobel Prize in Physiology or Medicine for groundbreaking work he conducted on cancer immunotherapy at the University of California, Berkeley, during his 20 years as director of the campus’s Cancer Research Laboratory.